ANIK
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (ANIK) has 6 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 23, 2026.
- Industry:Medical - Devices
- CEO:Stephen D. Griffin
- Employees:288
- HQ:Bedford, MA, US
- IPO:1993-05-03
Insider Buying
$73K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$210.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
HENNEMAN JOHN B IIIFirst filing | Insider | Purchase | 5,000 | $73K | May 4 | SEC ↗ |
Related companies
Anika Therapeutics, Inc. is in the Healthcare sector.